Join the Global Breast Cancer Movement
Save this page to myKomen
Go to myKomen
    Home > Understanding Breast Cancer > Breast Cancer Research > Research Table Topics

      


    Research Table Topics

    Loading...

    Risk Factors

    Established and Probable

     

    Table 1

    Body weight and breast cancer risk

    Table 2

    Weight gain and the risk of breast cancer

    Table 3

    Alcohol and breast cancer risk

    Table 4

    Physical activity and breast cancer risk

    Table 5

    Breastfeeding and breast cancer risk

    Table 6

    Blood estrogen levels and breast cancer risk

    Table 7 Blood androgen levels and breast cancer risk

    Table 8

    Postmenopausal hormone use and breast cancer risk

    Table 9

    Birth control pills and breast cancer risk

    Table 10

    Age at menopause and breast cancer risk women

    Table 11

    BRCA 1 and BRCA2 gene mutations and cancer risk

    Table 12

    Hyperplasia and breast cancer risk

    Table 13

    Light at night/shift work and breast cancer risk

    Factors Under Study

     

    Table 14

    Dietary fat consumption and breast cancer risk

    Table 15

    Fruit and vegetable consumption and breast cancer risk

    Table 16

    Carotenoid intake and breast cancer risk

    Table 17

    Soy intake and breast cancer risk

    Table 18

    Dairy/milk consumption and breast cancer risk

    Table 19

    Meat consumption and breast cancer risk

    Table 20

    IGF-1 and breast cancer risk

    Table 21

    Smoking and breast cancer risk

    Table 22

    Secondhand smoke and breast cancer risk

    Factors Not Related to Breast Cancer

     

    Table 23

    Electromagnetic fields and breast cancer risk

    Table 24

    Blood organochlorine levels and breast cancer risk

    Table 25

    Abortion and breast cancer risk

    Table 26

    Hair dyes and breast cancer risk

    Table 27

    Breast implants and breast cancer risk

     

    Risk-lowering drugs (Chemoprevention)

     

    Table 28

    Chemoprevention—the use of tamoxifen and raloxifene to reduce the risk of breast cancer

    Early Detection and Screening

     

    Table 29a

    Breast cancer screening with mammography for ages 40-49

    Table 29b

    Breast cancer screening with mammography for ages 50-69

    Table 29c

    Breast cancer screening with mammography for ages 70 and older

    Table 30

    Digital mammography versus standard mammography for breast cancer screening

    Table 31

    MRI plus mammography versus mammography alone for high-risk women

     

    Diagnosis and Prognostic Factors

     

    Table 32

    Lymph node status and breast cancer survival

    Table 33

    Accuracy of sentinel node biopsy in predicting axillary lymph node status

    Table 34

    Tumor size and breast cancer survival

    Table 35

    Estrogen receptor status and overall survival

    Treatment

     

    Table 36

    Mastectomy versus lumpectomy (breast conserving surgery) plus radiation and overall survival in early breast cancer

    Table 37

    Radiation therapy following mastectomy and overall survival in stage II & III breast cancer

    Table 38

    Adjuvant chemotherapy and overall survival

    Table 39

    Different adjuvant chemotherapy regimens and overall survival in early breast cancer

    Table 40

    Selected short-term side effects of chemotherapy

    Table 41

    Tamoxifen and overall survival in estrogen receptor-positive breast cancer

    Table 42

    Trastuzumab (Herceptin) and overall survival in early breast cancer

    Table 43

    Aromatase inhibitors and disease-free survival in early breast cancer

    Table 44

    Tamoxifen in the treatment of ductal carcinoma in situ (DCIS)

    Table 45

    Neoadjuvant (preoperative) chemotherapy for women with stage II or stage III breast cancer

    Table 46

    Neoadjuvant (preoperative) hormone therapy for women with estrogen receptor-positive breast cancer

    Table 47

    High-dose chemotherapy with stem cell transplant for women with metastatic breast cancer and for women with non-metastatic breast cancer at high risk for recurrence

    Table 48

    Combined modality treatment and overall survival in inflammatory breast cancer

    Table 49

    Trastuzumab (Herceptin) and overall response rate in metastatic breast cancer

    Support

     

    Table 50

    Support groups and breast cancer survival

    Table 51

    Social support and breast cancer survival

    Getting Good Care

     

    Table 52

    Hospital volume and breast cancer survival after treatment

    Table 53

    Geographic variation in rates of mastectomy

    After Treatment

     

    Table 54

    Pregnancy and breast cancer survival

    Table 55

    Postmenopausal hormones and recurrence after breast cancer diagnosis

    Table 56

    Total fat intake and breast cancer survival

    Table 57

    Body weight and breast cancer survival

    Table 58

    Physical activity and breast cancer survival

    Table 59

    Black cohosh and relief of menopausal symptoms

    Table 60

    Soy and relief of menopausal symptoms

    Table 61

    Other supplements and relief of menopausal symptoms

     

    previous How to Read a Research Table